Eugene Snell - Chemours President - Titanium Technologies
CC Stock | USD 27.32 0.29 1.07% |
President
Mr. Eugene Bryan Snell has appointed as President Titanium Technologies of the Company with effect on July1, 2015. Mr. Snell was appointed President Titanium Technologies in May 2015. Previously, he served as Planning Director DuPont Performance Chemicals . Prior to that, he held leadership positions in DuPont Titanium Technologies, including Planning Director and Global Sales and Marketing Director . Mr. Snell served as Regional Operations Director DuPont Coatings and Color Technologies Platform in 2007 and 2008. He was posted in Taiwan from 2002 to 2006, in the roles of Plant Manager Kuan Yin Plant and AsiaPacific Regional Director, DuPont Titanium Technologies. Mr. Snell joined DuPont in 1978 as a process engineer and has experience in nuclear and petrochemical operations, as well as sales, business strategy and MA. since 2015.
Age | 62 |
Tenure | 9 years |
Address | 1007 Market Street, Wilmington, DE, United States, 19801 |
Phone | 302 773 1000 |
Web | https://www.chemours.com |
Chemours Management Efficiency
The company has Return on Asset (ROA) of 0.0529 % which means that for every $100 of assets, it generated a profit of $0.0529. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.2568) %, which implies that it produced no returns to current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.01. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 2.11, whereas Total Assets are forecasted to decline to about 7.5 B.Similar Executives
Showing other executives | PRESIDENT Age | ||
David Sewell | Sherwin Williams Co | 51 | |
Alex Blanco | Ecolab Inc | 57 | |
Larry Berger | Ecolab Inc | 63 | |
Laurie Marsh | Ecolab Inc | 60 | |
Christophe Beck | Ecolab Inc | 56 | |
Brian Gallagher | Sherwin Williams Co | 52 | |
Michael Hickey | Ecolab Inc | 57 | |
Allen Mistysyn | Sherwin Williams Co | 55 | |
Mark Provenson | Sherwin Williams Co | 50 | |
Robert Wells | Sherwin Williams Co | 60 | |
Joshua Bagshaw | Sherwin Williams Co | 43 | |
Stephen Taylor | Ecolab Inc | 54 | |
Michael Monahan | Ecolab Inc | N/A | |
Jonathan Reid | Sherwin Williams Co | 52 | |
Martha Aronson | Ecolab Inc | 47 | |
James Seifert | Ecolab Inc | 59 | |
Thomas Gilligan | Sherwin Williams Co | 63 | |
Jane Cronin | Sherwin Williams Co | 56 | |
Richard Gilmore | Sherwin Williams Co | 55 | |
Bryan Hughes | Ecolab Inc | 46 | |
Thomas Hopkins | Sherwin Williams Co | 56 |
Management Performance
Return On Equity | -0.26 | |||
Return On Asset | 0.0529 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
Dawn Farrell, Independent Chairman of the Board | ||
Curtis Anastasio, Independent Director | ||
Bryan Snell, President - Titanium Technologies | ||
Jonathan Lock, Senior Vice President and Chief Development Officer | ||
Amber Wellman, Chief Officer | ||
Stephen Newlin, Independent Director | ||
Matthew Abbott, Vice President - Digital and Analytics Platforms Leader | ||
David Shelton, Senior Vice President, General Counsel, Secretary | ||
Paul Kirsch, President - Fluoroproducts | ||
Denise Dignam, President - Advanced Performance Materials | ||
Curtis Crawford, Independent Director | ||
Aditya Beri, Interim Business | ||
Mary Cranston, Independent Director | ||
Bradley Bell, Independent Director | ||
Sheryl Telford, Chief Sustainability Officer | ||
Ron Charles, Senior People | ||
Erin Kane, Independent Director | ||
Christian Siemer, President - Chemical Solutions | ||
Alisha Bellezza, President - Thermal & Specialized Solutions | ||
Joseph Martinko, President Solutions | ||
Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
Gerardo Calderon, President Materials | ||
Eugene Snell, President - Titanium Technologies | ||
Sandra Rogers, Independent Director | ||
Kurt Bonner, Ma Relations | ||
Elizabeth Albright, Sr. VP of HR | ||
Kristine Wellman, General VP | ||
Sean Keohane, Independent Director | ||
Thierry Vanlancker, President of Fluoroproducts | ||
Sameer Ralhan, Chief Financial Officer, Senior Vice President, Treasurer | ||
Guillaume Pepy, Independent Director | ||
Brandon Ontjes, Vice Relations | ||
Camela Wisel, Chief Accounting Officer, Vice President Controller | ||
Mark Newman, Chief Operating Officer, Senior Vice President | ||
Edwin Sparks, President - Chemical Solutions Business, Titanium Technologies | ||
Erich Parker, Senior Vice President of Corporate Communications and Chief Brand Officer. | ||
Mark Vergnano, President, Chief Executive Officer, Director | ||
Lori Ursomarso, IR Contact Officer | ||
Richard Brown, Independent Chairman of the Board | ||
Alvenia Scarborough, Senior Vice President - Corporate Communications and Chief Brand Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.26 | |||
Return On Asset | 0.0529 | |||
Profit Margin | (0.04) % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 7.13 B | |||
Shares Outstanding | 148.88 M | |||
Shares Owned By Insiders | 0.59 % | |||
Shares Owned By Institutions | 77.61 % | |||
Number Of Shares Shorted | 5.34 M | |||
Price To Earning | 25.49 X |
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
0.58 | ECL | Ecolab Inc Earnings Call This Week | PairCorr |
0.57 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
0.55 | ASH | Ashland Global Holdings Earnings Call This Week | PairCorr |
0.55 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
0.49 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.